These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 231199)

  • 41. Purine enzyme activities as markers of lymphocytic differentiation: studies of lymphocytes from horses with severe combined immunodeficiency (SCID).
    Magnuson N; Perryman L; Wyatt C; Mason P
    Adv Exp Med Biol; 1986; 195 Pt B():421-7. PubMed ID: 3020915
    [No Abstract]   [Full Text] [Related]  

  • 42. High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan.
    Kishi T; Sakura N; Ito K; Usui T
    Acta Paediatr Jpn; 1987 Feb; 29(1):152-4. PubMed ID: 3144840
    [No Abstract]   [Full Text] [Related]  

  • 43. Intranephron distribution of purine-metabolizing enzymes in rats.
    Takahashi T; Kakuno K; Yamada H; Endou H
    Ren Physiol Biochem; 1989; 12(5-6):287-94. PubMed ID: 2560234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substrate specificities of adenosine deaminase and adenosine phosphorylase from Bacillus cereus.
    Cercignani G
    Ital J Biochem; 1982; 31(4):243-52. PubMed ID: 6818177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency.
    Ito K; Sakura N; Usui T; Uchino H
    J Lab Clin Med; 1977 Nov; 90(5):844-8. PubMed ID: 409794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purine salvage pathway enzyme activities in human T-, B-, and null lymphocyte populations.
    Cowan MJ; Fraga M; Andrew J; Laméris-Martin N; Ammann AJ
    Cell Immunol; 1982 Feb; 67(1):121-8. PubMed ID: 6804097
    [No Abstract]   [Full Text] [Related]  

  • 47. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes.
    Hoffbrand AV; Ma DD; Webster AD
    Clin Haematol; 1982 Oct; 11(3):719-41. PubMed ID: 6293744
    [No Abstract]   [Full Text] [Related]  

  • 48. Enzymes of purine nucleotide metabolism in human lymphocytes.
    Van Laarhoven JP; Spierenburg GT; De Bruyn CH
    J Immunol Methods; 1980; 39(1-2):47-58. PubMed ID: 6257789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies.
    Demeocq F; Viallard JL; Boumsell L; Richard Y; Chassagne J; Plagne R; Lemerle J; Bernard A
    Leuk Res; 1982; 6(2):211-20. PubMed ID: 6821120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine deaminase and purine nucleoside phosphorylase activities during culturing of fibrolasts.
    Uitendaal MP; Oerlemans FT; de Bruyn CH; Oei TL; Hösli P
    Adv Exp Med Biol; 1980; 122A():415-20. PubMed ID: 6775503
    [No Abstract]   [Full Text] [Related]  

  • 51. Degradation of purine nucleosides by mitochondrial enzymes of bovine liver.
    Lewis RA; Link L; Chen W
    Adv Exp Med Biol; 1989; 253A():353-7. PubMed ID: 2516408
    [No Abstract]   [Full Text] [Related]  

  • 52. The distribution of adenosine deaminase, purine nucleotide phosphorylase and 5'-nucleotidase in subpopulations of thymocytes, bone marrow cells and other lymphoid organs in mice.
    Freire-Moar JM; Rodriguez D; Rodriguez-Segade S; Freire M
    Int J Biochem; 1984; 16(2):225-9. PubMed ID: 6323233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme defects and immune dysfunction.
    Rosen FS
    Nature; 1978 Dec; 276(5688):559-60. PubMed ID: 102999
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purine nucleoside phosphorylase (PNP) and adenosine deaminase (ADA) activities examined cytochemically in unfixed lymphocytes of patients with lymphoproliferative disorders.
    Maeda K; Ito K; Yamaguchi N
    Blood; 1981 Nov; 58(5):897-903. PubMed ID: 6794677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adenosine deaminase and purine nucleoside phosphorylase activity in T-and B-lymphocytes of peripheral blood].
    Krizko J; Rendeková V; Niks M; Pechánová E; Pechán I
    Bratisl Lek Listy; 1982 Jul; 78(1):19-26. PubMed ID: 6812861
    [No Abstract]   [Full Text] [Related]  

  • 59. Adenosine deaminase and nucleoside phosphorylase activities in normal human blood mononuclear cell subpopulations.
    MacDermott RP; Tritsch GL; Formeister JF
    Clin Exp Immunol; 1980 Nov; 42(2):303-7. PubMed ID: 6781801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
    Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
    Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.